
Key Takeaways
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
The S&P 500 slipped 0.3%. The Dow ended the session 0.5% lower, while the Nasdaq eked out a minimal gain of less than 0.1%.
Westinghouse Air Brake Technologies ( WAB ) shares dropped 9.1%, falling the most of any S&P 500 stock. The manufacturer of products for locomotives and railroad systems missed quarterly sales and profit forecasts. The company, commonly known as Wabtec, also issued lower-than-expected full-year earnings guidance, citing pressure on freight demand along with increased prices and borrowing costs.
Arista Networks ( ANET ) shares lost 6.2% following reports that the cloud networking firm's chief technology officer recently sold a significant stake in the company. Investors often view sales by company insiders as a possible warning signal about a stock's upcoming performance. Wednesday's downturn reversed a portion of strong gains posted by Arista stock over the past two weeks, boosted by expectations of robust demand for scalable cloud networking infrastructure.
Waters (
WAT
), which provides analytical instruments and software for scientific research laboratories, edged out fourth-quarter sales and profit expectations, but its first-quarter guidance came in below expectations. The company noted a negative impact from currency exchange as the strength of the U.S. dollar pressures its international revenue. Waters shares tumbled 5.8% on Wednesday.
The top performance in the S&P 500 Wednesday came from shares of CVS Health ( CVS ), which surged 14.9% after the pharmacy operator and health insurance provider topped fourth-quarter sales and profit estimates . CEO David Joyner, who took the reigns of CVS amid a strategic reshuffling in October, noted strong growth in the pharmacy and consumer wellness business as the company navigates a challenging environment in the health care benefits segment.
Shares of Generac Holdings ( GNRC ) were 7.6% higher after the provider of portable, residential, and commercial generators outperformed profit expectations with its fourth-quarter results. The company noted that declining power quality and increasing prices, as well as the prevalence of extreme weather and power outages, contributed to strong demand.
Gilead Sciences (
GILD
) posted better-than-expected revenue and adjusted earnings per share for the fourth quarter, and shares of the biopharmaceutical company jumped 7.5%. During the earnings call, Gilead suggested that it expects the Food and Drug Administration (FDA) to approve its antiretroviral drug lenacapavir as a pre-exposure prophylactic for HIV, with preparations underway for a launch in the middle of this year.
Read the original article on Investopedia